braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - Αντινεοπλασματικοί παράγοντες - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
cleron 250mg film coated tablets
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - clarithromycin - film coated tablets - 250mg - clarithromycin (8000001318) 250mg - clarithromycin
elitan 10mg/2ml solution for injection or infusion
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - metoclopramide hydrochloride anhydrous - solution for injection or infusion - 10mg/2ml - metoclopramide hydrochloride anhydrous (0007232215) 10mg - metoclopramide
amlodipine/valsartan/hydrochlorothiazide genepharm 10mg/160mg/25mg film coated tablets
genepharm sa (0000003668) 18th km marathon ave., pallini, 153 51 - amlodipine besylate; valsartan; hydrochlorothiazide - film coated tablets - 10mg/160mg/25mg - amlodipine besylate (8000001302) 13,888mg; valsartan (8000001531) 160mg; hydrochlorothiazide (0000058935) 25mg
amlodipine/valsartan/hydrochlorothiazide genepharm 10mg/320mg/25mg film coated tablets
genepharm sa (0000003668) 18th km marathon ave., pallini, 153 51 - amlodipine besylate; valsartan; hydrochlorothiazide - film coated tablets - 10mg/320mg/25mg - amlodipine besylate (8000001302) 13,888mg; valsartan (8000001531) 320mg; hydrochlorothiazide (0000058935) 25mg
giotrif
boehringer ingelheim international gmbh - afatinib - Καρκίνωμα, μη μικροκυτταρικός πνεύμονας - Αντινεοπλασματικοί παράγοντες - giotrif ως μονοθεραπεία ενδείκνυται για τη θεραπεία ofepidermal αυξητικού Παράγοντα (egfr) tki-πρωτοθεραπευόμενους ενήλικες ασθενείς με τοπικά προχωρημένο ή μεταστατικό μη-μικροκυτταρικό καρκίνο του πνεύμονα (nsclc) με την ενεργοποίηση του egfr mutation(s) * τοπικά προχωρημένο ή μεταστατικό μη μικροκυτταρικό καρκίνο του πνεύμονα από πλακώδη ιστολογία, προχωράει ή μετά από χημειοθεραπεία με βάση την πλατίνα.
kaftrio
vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - Κυστική ίνωση - Άλλα προϊόντα του αναπνευστικού συστήματος - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.
moxilen 500mg/vial powder for solution for injection/infusion
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - amoxicillin sodium - powder for solution for injection/infusion - 500mg/vial - amoxicillin sodium (0034642778) 500mg base - amoxicillin
moxilen 500mg capsule,hard
medochemie ltd (0000003169) 1-10 constantinoupoleos str, lemesos, 3011, 51409 (3505) - amoxicillin trihydrate - capsule,hard - 500mg - amoxicillin trihydrate (0061336707) 574mg - amoxicillin
rebetin 6mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - rivastigmine hydrogen tartrate - capsule,hard - 6mg - rivastigmine hydrogen tartrate (8000003317) 9.6mg - rivastigmine